Journal
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Volume 1774, Issue 6, Pages 764-771Publisher
ELSEVIER
DOI: 10.1016/j.bbapap.2007.04.001
Keywords
biomarkers; pancreatic carcinoma; serum proteomics; two-dimensional electrophoresis
Categories
Ask authors/readers for more resources
To identify new biomarkers that improve the early diagnosis and lead to possible therapeutic targets in pancreatic carcinoma, we performed a proteomic approach to compare serum protein expression patterns of pancreatic carcinoma patients with that of gastric cancer patients, other pancreatic disease patients, and healthy volunteers. By two-dimensional gel electrophoresis (2-DE) analyses and mass spectroscopic identification, 10 protein spots were found significantly changed in pancreatic carcinoma and 5 proteins including cyclin 1, Rab GDP dissociation inhibitor beta (GD12), alpha-1 antitrypsin precursor, Haptoglobin precursor, and Serotransferrin precursor were successfully identified. The increased levels of cyclin I and GD12 found to be associated with pancreatic carcinoma were further confirmed by Western blot analyses in an independent series of serum samples and/or pancreatic juice samples. Applying immunohistochemistry, we further validated expression of cyclin I and GD12 in additional pancreatic carcinomas. These results indicate that cyclin I and GD12 may be potential molecular targets for pancreatic cancer diagnostics and therapeutics. (c) 2007 Elsevier B.V All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available